EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

N -Substituted l -Iminosugars for the Treatment of Sanfilippo Type B Syndrome

Valeria De Pasquale, Anna Esposito iD, Gianluca Scerra, Melania Scarcella, Mariangela Ciampa, Antonietta Luongo, Daniele D'Alonzo iD, Annalisa Guaragna iD, Massimo D'Agostino, Luigi Michele Pavone iD

Journal of Medicinal Chemistry · 2023

DOI: 10.1021/acs.jmedchem.2c01617 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2023. Verfasst von Valeria De Pasquale und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Medicine and Animal Productions, University of Naples Federico II, Via F. Delpino 1, 80137 Naples, Italy. Hauptthemen laut MEDLINE: Mucopolysaccharidosis III. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cure Sanfilippo Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sanfilippo syndrome comprises a group of four genetic diseases due to the lack or decreased activity of enzymes involved in heparan sulfate (HS) catabolism. HS accumulation in lysosomes and other cellular compartments results in tissue and organ dysfunctions, leading to a wide range of clinical symptoms including severe neurodegeneration. To date, no approved treatments for Sanfilippo disease exist. Here, we report the ability of N-substituted l-iminosugars to significantly reduce substrate storage and lysosomal dysfunctions in Sanfilippo fibroblasts and in a neuronal cellular model of Sanfilippo B subtype. Particularly, we found that they increase the levels of defective α-N-acetylglucosaminidase and correct its proper sorting toward the lysosomal compartment. Furthermore, l-iminosugars reduce HS accumulation by downregulating protein levels of exostosin glycosyltransferases. These results highlight an interesting pharmacological potential of these glycomimetics in Sanfilippo syndrome, paving the way for the development of novel therapeutic approaches for the treatment of such incurable disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mucopolysaccharidosis IIIHumansHeparan SulfateLysosomesFibroblastsNeurons

Substanzen

Heparan Sulfate

Autor:innen und Institutionen

  • Department of Veterinary Medicine and Animal Productions, University of Naples Federico II, Via F. Delpino 1, 80137 Naples, Italy.
  • Department of Chemical, Materials and Production Engineering, University of Naples Federico II, Piazzale V. Tecchio 80, 80125 Naples, Italy.
  • Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Via S. Pansini 5, 80131 Naples, Italy.
  • AORN Sant'Anna e San Sebastiano, Via F. Palasciano, 81100 Caserta, Italy.
  • Department of Chemical Sciences, University of Naples Federico II, Via Cintia, 80126 Napoli, Italy.

ORCID-Profile: Anna Esposito, Daniele D'Alonzo, Annalisa Guaragna, Luigi Michele Pavone

Förderung

  • Cure Sanfilippo Foundation

Zitieren

APA

De Pasquale, V., Esposito, A., Scerra, G., Scarcella, M., Ciampa, M., Luongo, A., D'Alonzo, D., Guaragna, A., D'Agostino, M., & Pavone, L. M. (2023). N -Substituted l -Iminosugars for the Treatment of Sanfilippo Type B Syndrome. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.2c01617

Vancouver

De Pasquale V, Esposito A, Scerra G, Scarcella M, Ciampa M, Luongo A, et al. N -Substituted l -Iminosugars for the Treatment of Sanfilippo Type B Syndrome. Journal of Medicinal Chemistry. 2023. doi:10.1021/acs.jmedchem.2c01617

BibTeX
@article{DePasquale2023,
  author = {De Pasquale, Valeria and Esposito, Anna and Scerra, Gianluca and Scarcella, Melania and Ciampa, Mariangela and Luongo, Antonietta and D'Alonzo, Daniele and Guaragna, Annalisa and D'Agostino, Massimo and Pavone, Luigi Michele},
  title = {N -Substituted l -Iminosugars for the Treatment of Sanfilippo Type B Syndrome},
  journal = {Journal of Medicinal Chemistry},
  year = {2023},
  doi = {10.1021/acs.jmedchem.2c01617}
}
Kostenlos starten →